- Home
- /
- Treatment
- /
- Page 51
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
| Country | Product | Indication | Sponsor | Date |
|---|---|---|---|---|
|
Triheptanoin | Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency | Ultragenyx UK Limited | July 28, 2015 |
|
Allogeneic human adult stem cells, isolated from skeletal muscle and expanded ex vivo | Duchenne muscular dystrophy | Karl Rouger | July 28, 2015 |
|
Triheptanoin | Carnitine palmitoyltransferase II deficiency | Ultragenyx UK Limited | July 28, 2015 |
|
Cannabidiol | Perinatal asphyxia | GW Pharma Ltd | July 28, 2015 |
|
Humanised IgG4 monoclonal antibody against extracellular tau | Progressive supranuclear palsy | Biogen Idec Limited | July 28, 2015 |
|
Triheptanoin | Mitochondrial trifunctional protein deficiency | Ultragenyx UK Limited | July 28, 2015 |
|
Hydrocinnamate-[Orn-Pro-dCha-Trp-Arg]acetate | Amyotrophic lateral sclerosis | PBS Regulatory Consulting Group Limited | July 28, 2015 |
|
Synthetic double-stranded RNA oligonucleotide specific to hydroxyacid oxidase 1 gene | Primary Hyperoxaluria Type 1 | Dicerna EU Limited | July 28, 2015 |
|
Glycyl-L-2-methylprolyl-L-glutamic acid | Fragile X syndrome | QRC Consultants Ltd | July 28, 2015 |
|
Sarizotan hydrochloride | Rett syndrome | Newron Pharmaceuticals SpA | July 28, 2015 |
|
Human plasminogen | Plasminogen deficiency | ProMetic BioTherapeutics Ltd | July 28, 2015 |
|
Antroquinonol | Hepatocellular Carcinoma | Golden Biotechnology Corporation;10F, No. 9, Ln. 3, Tamsui Dist., New Taipei City 251; | July 23, 2015 |
|
Cannabidiol | West syndrome | Insys Development Company, Inc.;1333 South Spectrum Boulevard, Suite 100;Chandler, Arizona, 85286 | July 23, 2015 |
|
Procaspase-activating compound 1 | Glioma | Vanquish Oncology, Inc.;2001 S. First Street, Suite 201;Champaign, Illinois, 61820 | July 23, 2015 |
|
Adenoviral vector-RheoSwitch Therapeutic System-human interleukin 12 + veledimex | Glioma | Ziopharm Oncology, Inc.;One First Avenue, Navy Yard Plaza;Boston, Massachusetts, 02129 | July 23, 2015 |
|
Mongersen | pediatric Crohn’s disease | Celgene Corporation;86 Morris Avenue;Summit, New Jersey, 07901 | July 20, 2015 |
|
Amantadine HCl | Levodopa-induced dyskinesia | Osmotica Pharmaceutical Corporation;Regulatory, Clinical Operations & Legal, Lumina Station #2, Suite 209-A;Wilmington, North Carolina, 28403 | July 20, 2015 |
|
Adeno-associated virus serotype 9 vector containing human Iduronate-2-sulfatase transgene | Hunter Syndrome | Laboratorios del Dr. Esteve, S.A.;Av. Marie de Deu de Montserrat, 221;Barcelona | July 16, 2015 |
|
Recombinant humanized anti-matrix metalloprotein 9 (MMP9) monoclonal antibody IgG4 | Stomach Cancer | Gilead Sciences, Inc.;199 E. Blaine St.;Seattle, Washington, 98102 | July 16, 2015 |
|
Ombitasvir/paritaprevir/ritonavir and dasabuvir | Pediatric patients with hepatitis C virus infection (0 through 16 years of age) | Abbvie, Inc.;1 North Waukegan Road;North Chicago, Illinois, 60064 | July 16, 2015 |
|
DPX-Survivac | Ovarian cancer | Immunovaccine Technologies, Inc.;1344 Summer Street, Halifax, Nova Scotia B3H; | July 14, 2015 |
|
Anisina | Neuroblastoma | Novogen Ltd;16-20 Edgeworth David Avenue, Hornsbsy, NSW 2077; | July 14, 2015 |
|
Adenovirus vaccine encoding reduced expression in immortalized cell protein | Malignant pleural mesothelioma | MTG Biotherapeutics;8195 Run of the Knolls Court;San Diego, California, 92127 | July 14, 2015 |
|
Cannabidiol | Graft Versus Host Disease | Talent biotechs Ltd.;14 - 18 Baruch Hirsch St., Bnei Brak 5120206; | July 14, 2015 |
|
Melphalan | Bile duct cancer | Delcath Systems, Inc.;1633 Broadway, Suite 22C;New York, New York, 10019 | July 14, 2015 |
